In patients, high expression levels of cyclin A1 and aromatase proteins in metastatic bone lesions support the notion that stem cell-like prostate cancer cells overexpressing cyclin A1 and aromatase, preferentially metastasize to bone [70]. The gene discussed is CCNA1; the disease is Familial prostate cancer.